ArticlePurinergic signalling2022

Selectivity of the P2X3 receptor antagonist Eliapixant, and its potential use in the treatment of endometriosis.

Michelle C FletcherPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.